stockportfolio.pro
IQV vs TEVA: Which Stock Is the Better Buy?
IQVIA Holdings Inc. and Teva Pharmaceutical Industries Limited side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — IQV vs TEVA, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| IQVIA Holdings Inc. (IQV) | Teva Pharmaceutical Industries Limited (TEVA) | |
|---|---|---|
| Market cap | $34.6B | $40.1B |
| Revenue (latest FY) | $16.31B | $17.26B |
| Net income (latest FY) | $1.36B | $1.41B |
| Revenue growth (5y CAGR) | 7.5% | 0.7% |
| Net margin | 8.3% | 8.2% |
| Return on equity | 20.9% | 17.8% |
| P/E ratio | 25.7 | 25.7 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 10 | 3 |
| Positive free cash flow | Yes | Yes |
See the full IQV vs TEVA breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open IQV's full financials → Open TEVA's full financials →Frequently asked questions
Which is bigger, IQV or TEVA?
Teva Pharmaceutical Industries Limited is larger by market capitalization — $40.1B versus $34.6B.
Which grows faster, IQV or TEVA?
Over the last five fiscal years, IQVIA Holdings Inc. grew revenue faster — 7.5%/yr versus 0.7%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.
Keep exploring
IQV fundamentals → · TEVA fundamentals → · All 1,500+ companies → · Free screener →